Effects of PEMF Treatment on Patients With Mild to Moderate Alzheimer's Disease in a Controlled Pilot Study
Herrick Medical LLC
Summary
An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
Eligibility
- Age range
- 50–100 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Age ≥ 50 years 2. Patients diagnosed with mild to moderate Alzheimer's Dementia defi 3. At least an eighth grade of educational achievement 4. If female, post-menopausal. 5. MMSE score between 16 and 26 6. Capable of providing consent or having a surrogate (e.g., spouse, family member) capable of providing consent if participant lacks consent capacity 7. Able and willing to comply with the protocol 8. If the participant is receiving a cholinesterase inhibitor and/or memantine, such medication has been prescribed for at least 3 months prior to screening and the dose is s…
Interventions
- DeviceECHS AD Device
Pulsed electromagnetic therapy device
Location
- Hackensack Medical CenterHackensack, New Jersey